BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medical Diagnostic

AstraZeneca's TAGRISSO® (osimertinib) with Chemotherapy Approved in the US for EGFR-Mutated Advanced Lung Cancer

AstraZeneca’s TAGRISSO® (osimertinib) with the addition of chemotherapy has been approved in the US for the treatment of adult patients with...

February 17, 2024 | News

FDA Prioritizes Review of Bristol Myers Squibb's Augtyro™ for NTRK-Positive Solid Tumors

Bristol Myers Squibb (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for A...

February 15, 2024 | News

William Lin Discusses QIAGEN's Role in Transforming Healthcare in Asia-Pacific with Innovative Molecular Diagnostics

In a significant stride towards enhancing healthcare diagnostics in the Asia-Pacific region, QIAGEN has recently garnered attention with the approval of it...

February 13, 2024 | Interaction

GE HealthCare and MedQuest Associates Join Forces to Enhance Outpatient Imaging Centers with Cutting-Edge Technology

GE HealthCare (Nasdaq: GEHC) and MedQuest Associates (MedQuest) have announced a strategic three-year collaboration aimed at elevating patient care standar...

February 12, 2024 | News

CooperSurgical® and Fulgent Genetics Introduce Advanced Genetic Testing for Cord Blood Registry® Families

CooperSurgical®, a global leader in fertility and women's health, and Fulgent Genetics, Inc. (NASDAQ: FLGT), a technology-...

February 12, 2024 | News

Bruker acquires Spectral Instruments Imaging, enhancing its preclinical optical imaging capabilities

-Bruker Corporation (Nasdaq: BRKR) announced that it has acquired Spectral Instruments Imaging LLC, a leader in preclinical in-vivo opt...

February 07, 2024 | News

Jiva.AI and Aevice Health Partner to Advance Medical AI for Asthma Prediction Using FDA-Cleared Remote Patient Monitor

The collaboration represents a synergistic blend of Jiva.ai's cutting-edge AI capabilities and Aevice Health's expertise in developing a proprietary ...

February 06, 2024 | News

Agilis Robotics Reveals Innovative Breakthroughs in Endoluminal Surgery

This achievement empowers surgeons to perform intricate tissue resection procedures with precision and ease, directly within natural orifices. Uniquely, th...

February 05, 2024 | News

DELFi Diagnostics Launches Fragmentome-Based Cancer Treatment Monitoring Assay

DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to enhance cancer detection, announced availability of the comp...

February 04, 2024 | News

ASPIRE Consortium Tackles Rising Lung Cancer in Asia-Pacific

Lung cancer has a significant health and economic impact in the region. It is the most prevalent cancer, accounting for about 1 million deaths per year, an...

February 04, 2024 | News

Lumosa Therapeutics and CHI Memorial initiate a new Acute Stroke Study in Taiwan

Stroke, a leading cause of adult disability globally, hits particularly hard in Chattanooga, Tenn., an area known as the "Stroke Belt," with one of th...

February 02, 2024 | News

QIAGEN Digital Insights Introduces Rapid NGS Analysis for Somatic Cancer

New software accelerator significantly reduces time and cost of NGS secondary analysis for somatic cancer, analyzing a 275-gene comprehensive cancer pane...

February 02, 2024 | News

Biosyngen's BST02 Granted FDA Fast Track for Liver Cancer Treatment

Fast track is a process designed to facilitate development, and accelerate the review of drugs to treat serious or life-threatening conditions and fill an ...

February 02, 2024 | News

LabCorp Launches New Test for Severe Preeclampsia Risk in Pregnant Women

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced the launch and availability of a new, FDA-cle...

February 01, 2024 | News

Stay Connected